Urology
Volume 68, Issue 3, Supplement , Pages 38-46, September 2006

A prospective study of the beneficial effects of dose optimization and customized instructions on patient satisfaction with sildenafil citrate (Viagra®) for erectile dysfunction

  • Andrew R. Mccullough

      Affiliations

    • Department of Urology, New York University School of Medicine, New York, New York, USA
    • Andrew R. McCullough is a member of the medical advisory board for, and receives honoraria and research grants from, Pfizer Inc.
    • Corresponding Author InformationReprint requests: Andrew R. McCullough, MD, Department of Urology, New York University School of Medicine, 150 East 32nd Street, 2nd Floor, New York, NY 10016.
  • ,
  • Culley C. Carson

      Affiliations

    • Division of Urology, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    • Culley C. Carson is a paid consultant to, meeting participant and lecturer for, and study investigator who is partially funded by, Pfizer Inc.
  • ,
  • Dimitrios Hatzichristou

      Affiliations

    • 2nd Department of Urology, Papageorgiou General Hospital, and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Thessaloniki, Greece.
    • Dimitrios Hatzichristou is a meeting participant and lecturer for Pfizer Inc.

Abstract 

Our objective was to assess the effects of customized instructions and dose optimization on treatment satisfaction and improvement in erectile function (EF) with sildenafil citrate in men with erectile dysfunction (ED) who had not been previously treated with a phosphodiesterase-5 inhibitor. This 8-week, multicenter, open-label, flexible-dose (25, 50, or 100 mg sildenafil) study included 2 phases. During phase 1, patients took 50 mg sildenafil and followed the sildenafil sample package instructions. In phase 2, sildenafil dose could be adjusted on the basis of efficacy and tolerability, and investigators provided additional customized instructions. The primary efficacy variable was the satisfaction rate (defined as patients responding “very” or “somewhat” satisfied to the Erectile Dysfunction Inventory of Treatment Satisfaction [EDITS] Question 1). Other efficacy assessments included the International Index of Erectile Function (IIEF) and the percentage of successful sexual intercourse attempts. Of 1109 men (mean age, 54±13 years) treated, 867 completed the study. In phase 1, 75% of patients were very or somewhat satisfied with treatment. Mean EF domain score on the IIEF increased from 14.3 at baseline to 23.5, and 79% of sexual intercourse attempts were successful. In phase 2, 53% of patients increased their sildenafil dose to 100 mg and 2% decreased to 25 mg. Satisfaction with sildenafil increased to 86%, 91% of sexual intercourse attempts were successful, and mean IIEF EF domain score increased to 25.7. Of the 196 men who were not initially satisfied at the end of phase 1, 64% became very or somewhat satisfied with treatment by the end of phase 2. Initially high levels of efficacy and satisfaction with sildenafil were achieved when patients were provided with only the sample package instructions and the recommended 50-mg starting dose. These results were enhanced with dose optimization, individual patient counseling, and customized instructions.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(06)00627-3

doi:10.1016/j.urology.2006.04.040

Urology
Volume 68, Issue 3, Supplement , Pages 38-46, September 2006